tradmap

ITRI Itron, Inc.

$99.76 +4.01%

Data as of close

Healthcare · Instruments For Meas & Testing Of Electricity & Elec Signals

Itron, Inc. (ITRI) is a healthcare company in the Instruments For Meas & Testing Of Electricity & Elec Signals industry, with a market capitalization of $4.4 billion. Shares last traded at $99.76, 7.7% below their 52-week high. Over the past year the stock is down 8.4%. ITRI trades at a price-to-earnings ratio of 15.64, below the Instruments For Meas & Testing Of Electricity & Elec Signals median of 50.03. Net profit margin is 12.1%, above the peer median of 2.6%. Revenue declined 3.0% year over year.

Market Cap
$4.4B
Shares Out
43.9M
EPS (TTM)
$6.18
P/E (TTM)*
15.64
P/S Ratio
1.89
P/B Ratio
2.58
Dividend / Share
—
Dividend Yield
—
52-Week High
$108.06
52-Week Low
$77.77
Volume (venue)
49,439
Avg Vol (3m, venue)
32,196.556

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+13.56%
1M
+15.31%
3M
-6.14%
6M
+18.46%
YTD
+7.44%
1Y
-8.44%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
70.94
SMA (50)
$91.05
SMA (200)
$90.90
Price vs SMA50
+9.56%
Price vs SMA200
+9.74%
ATR (14)
$3.42

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2.3B
Net Income
$280M
Gross Margin
40.7%
Operating Margin
13.7%
Net Margin
12.1%
Return on Equity
16.5%
Return on Assets
6.8%
Current Ratio
2.83
Debt / Equity
0.93
Revenue Growth (YoY)
-3.0%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 $1.61 2026-10-27
Q2 2026 $1.19 2026-07-28
Q1 2026 $1.18 2026-04-28
Q4 2025 (derived) $2.20 2026-02-17
FY 2025 $6.50 2026-02-17
Q3 2025 $1.41 2025-10-30

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Instruments For Meas & Testing Of Electricity & Elec Signals peers

ITRI vs 10 industry peers (Instruments For Meas & Testing Of Electricity & Elec Signals), by market cap. Data as of close

P/E vs peers
15.64 / 50.03 med
-69% discount
P/S vs peers
1.89 / 3.26 med
-42% discount
Net margin vs peers
12.1% / 2.6% med
above median
1–10 of 10
TERTeradyne$40.7B29.668.1427.5%-4.82%
VLTOVeralto$28.1B28.084.8517.3%+4.18%
ITRIItron, Inc.$4.4B15.641.8912.1%+4.01%
COHUCohu Inc$2.3B—4.02-4.0%-4.89%
AEHRAehr Test Systems$1.9B—38.66-14.3%+8.04%
ALNTAllient Inc$1.4B50.032.495.0%-1.55%
TRNSTranscat Inc$822M152.832.361.5%+1.73%
FEIMFREQUENCY ELECTRONICS INC$740M276.3010.163.7%-3.26%
INTTINTEST CORP$175M295.731.440.5%-2.90%
DAIODATA I/O CORP$24M—1.37-50.1%-1.67%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.